Preparative chiral SFC as a green technology for rapid access to enantiopurity in pharmaceutical process research

LC-GC North America

Volumn 23, Issue 1, 2005, Pages 16-29

  Welch, Christopher J ^a   Leonard Jr , William R ^c   DaSilva, Jimmy O ^c   Biba, Mirlinda ^c   Albaneze Walker, Jennifer ^c   Henderson, Derek W ^c   Laing, Brian ^c   Mathre, David J ^c   Majors, Ronald E ^b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b AGILENT TECHNOLOGIES   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHIRAL CHROMATOGRAPHY; DRUG INDUSTRY; DRUG PURITY; ENANTIOMER; ENVIRONMENTAL IMPACT ASSESSMENT; GREENHOUSE GAS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTERMETHOD COMPARISON; PHARMACEUTICAL ENGINEERING; PROCESS DEVELOPMENT; REVIEW; SUPERCRITICAL FLUID CHROMATOGRAPHY;

EID: 11844264848     PISSN: 15275949     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. P.T. Anastas and J. Warner, Green Chemistry Theory and Practice. (Oxford University Press, Oxford, UK, 1998).
2. A.M. Katti and P. Jagland, Analusis 26, 38-46 (1998).
3. C.J. Welch, Chiral Chromatography in Support of Pharmaceutical Process Research, in Preparative Enantioselective Chromatography, G. Cox, Ed. (Blackwell, London, UK, in press).
4. Chiral Chemistry Special Issue, Chem. Eng. News 81(18) (2003).
5. M.K. O'Brien and B. Vanasse, Current Opinion Drug Disc. Devel 3(6), 793-806 (2000).
6. R.A. Sheldon, J. Chem. Technol. Biotechnol. 67(1), 1-14 (1996).
7. A.M. Rouhi, C&E News, 45-55 (May 5, 2003).
8. E.R. Francotte, J. Chromatogr, 906, 379-397 (2001).
9. S. Andersson and S.G. Allenmark, J. Biochem, Biophys. Meth. 54, 11-23 (2002).
10. J. Blehaut, O. Ludemann-Hombourger, and S.R. Perrin, Chim. Oggi, 24-28 (Sept. 2001).
11. C.J. Welch, F. Fleitz, F. Antia, R Yehl, R. Waters, N. Ikemoto, J.D. Armstrong, and D.J. Mathre, Organic Process Res. Devel. 8(2), 186-191 (2004).
12. P. Franco, M. Schaeffer, T. Zhang, and D. Heckmann, Chim, Oggi, 28-30 (Mar./Apr. 2004).
13. R.B. Woodward, Pure Appl. Chem. 33(1), 145-77 (1973).
14. B.M. Trost, Accounts Chem. Res. 35(9), 695-705 (Sept. 2002).
15. K.M.J. Brands, J.F. Payack, J.D. Rosen, T.D. Nelson, A. Candelario, M.A. Huffman, M.M. Zhao, J. Li, B. Craig, Z.J. Song, D.M. Tschaen, K. Hansen, P.N. Devine, P.J. Pye, K. Rossen, P.G. Dormer, R.A. Reamer, C.J. Welch, D.J. Mathre, N.N. Tsou, J.M. McNamara, and P.J. Reider, J. Am. Chem. Soc. 125(8), 2129-2135 (2003).
16. G. Terfloth, J. Chromatogr., A 906, 301-307 (2001).
17. J.F. Parcher, and T.L. Chester, ACS Symposium Series 748 (American Chemical Society, Washington, DC, 2000).
18. T.A. Berger, J. Smith, K. Fogelman, and K. Kruluts, Am. Lab. 34, 14 (2002).
19. P. Jusforgues and M. Shaimi, Analusis 26, 55-60 (1998).
20. W.H. Pirkle and R.W. Anderson, J. Organ. Chem., 3901-3903 (1974).
21. Y. Leblanc, C. Dufresne, R. Carson, L. Morency, and C.J. Welch, Tetrahedron: Asymmetry 12, 3063-3066 (2001).
22. J.T. Kuethe, I.W. Davies, P.G. Dormer, C.J. Welch, D.L. Hughes, and P.J. Reider, J. Org. Chem. 67, 5993-6000 (2002).
23. C.J. Welch, M.H. Kress, M. Beconi, and D.J. Mathre, Chirality 15, 143-147 (2003).
24. T.D. Nelson, C.J. Welch, J.D. Rosen, J.H. Smitrovich, M.A. Huffman, J.M. McNamara, and D.J. Mathre, Chirality 15, 609-613 (2004).
25. B.V. Karanam, C.J. Welch, V.G. Reddy, J. Chilenski, M. Biba, and S. Vincent, Drug Metabolism & Disposition 32, 1061-1068 (2004).
26. S. Mao, M. Bouygues, C.J. Welch, M. Biba, J. Chilenski, R.F. Schinazi, and D.C. Liotta, Bioorgan, Medicinal Chem. Lett. 14, 4991-4994 (2004).
27. J. Blehaut and R.M. Nicoud, Analusis 26, 60-70 (1998).
28. M. Johannsen, S. Peper, and A. Depta, J. Biochem. Biophys. Meth. 54(1-3), 85-102 (2002).
29. A. Depta, T. Giese, M. Johannsen, and G. Brunner, J. Chromatogr., A 865(1-2), 175-186 (1999).